6 Reasons Why India Is The Future Of Global Production Of APIs
Source: Life Science Leader
By Frédéric Kahn
India made a remarkably bold contribution to the worldwide fight against the COVID-19 pandemic when it supplied 65 million vaccines to 100 countries while providing medical supplies and medications to 150 additional countries. Consequently, “Pharmacy of the World” is the newest honorific by which India refers to itself. And rightly so. The pandemic showcased India’s ability to produce APIs, generic medications, vaccines, and other necessities. However, this industry’s development began much earlier.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more